Insider Selling: Alignment Healthcare (NASDAQ:ALHC) President Sells 16,681 Shares of Stock

by · The Markets Daily

Alignment Healthcare, Inc. (NASDAQ:ALHC – Get Free Report) President Dawn Christine Maroney sold 16,681 shares of the firm’s stock in a transaction dated Friday, December 12th. The shares were sold at an average price of $20.02, for a total value of $333,953.62. Following the transaction, the president directly owned 1,780,556 shares in the company, valued at approximately $35,646,731.12. This represents a 0.93% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website.

Dawn Christine Maroney also recently made the following trade(s):

  • On Monday, December 15th, Dawn Christine Maroney sold 113,319 shares of Alignment Healthcare stock. The shares were sold at an average price of $20.01, for a total value of $2,267,513.19.

Alignment Healthcare Trading Up 3.9%

NASDAQ ALHC traded up $0.75 on Monday, hitting $20.11. The company’s stock had a trading volume of 3,366,998 shares, compared to its average volume of 3,039,179. The company has a current ratio of 1.61, a quick ratio of 1.61 and a debt-to-equity ratio of 1.99. The firm has a market cap of $4.02 billion, a P/E ratio of -167.58 and a beta of 1.16. The company’s 50-day simple moving average is $17.65 and its 200 day simple moving average is $15.84. Alignment Healthcare, Inc. has a 52-week low of $10.18 and a 52-week high of $21.06.

Alignment Healthcare (NASDAQ:ALHC – Get Free Report) last posted its earnings results on Thursday, October 30th. The company reported $0.02 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.01) by $0.03. The firm had revenue of $993.70 million for the quarter, compared to the consensus estimate of $980.90 million. Alignment Healthcare had a negative return on equity of 16.23% and a negative net margin of 0.57%.The business’s revenue for the quarter was up 43.5% on a year-over-year basis. During the same quarter in the prior year, the business earned ($0.14) EPS. Research analysts predict that Alignment Healthcare, Inc. will post -0.69 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

ALHC has been the subject of several research reports. JPMorgan Chase & Co. raised shares of Alignment Healthcare from a “neutral” rating to an “overweight” rating and boosted their price objective for the company from $18.00 to $20.00 in a report on Monday, November 24th. Wall Street Zen raised shares of Alignment Healthcare from a “hold” rating to a “buy” rating in a research note on Saturday, November 8th. UBS Group increased their price objective on shares of Alignment Healthcare from $17.00 to $18.00 and gave the company a “neutral” rating in a report on Friday, October 31st. The Goldman Sachs Group restated a “buy” rating and set a $22.00 price target on shares of Alignment Healthcare in a report on Monday, November 3rd. Finally, KeyCorp reiterated an “overweight” rating on shares of Alignment Healthcare in a research report on Monday, November 24th. One analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, Alignment Healthcare currently has a consensus rating of “Moderate Buy” and an average price target of $20.05.

Get Our Latest Research Report on ALHC

Institutional Trading of Alignment Healthcare

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Integrated Wealth Concepts LLC lifted its position in Alignment Healthcare by 6.3% during the third quarter. Integrated Wealth Concepts LLC now owns 11,230 shares of the company’s stock valued at $196,000 after purchasing an additional 665 shares during the period. Universal Beteiligungs und Servicegesellschaft mbH grew its position in shares of Alignment Healthcare by 2.3% in the third quarter. Universal Beteiligungs und Servicegesellschaft mbH now owns 37,752 shares of the company’s stock valued at $659,000 after purchasing an additional 844 shares during the period. Tidal Investments LLC increased its stake in Alignment Healthcare by 4.9% during the 2nd quarter. Tidal Investments LLC now owns 18,094 shares of the company’s stock worth $253,000 after buying an additional 852 shares in the last quarter. Jefferies Financial Group Inc. increased its position in shares of Alignment Healthcare by 4.3% during the third quarter. Jefferies Financial Group Inc. now owns 24,359 shares of the company’s stock worth $425,000 after purchasing an additional 1,014 shares in the last quarter. Finally, Ballentine Partners LLC raised its holdings in Alignment Healthcare by 10.2% in the 2nd quarter. Ballentine Partners LLC now owns 12,862 shares of the company’s stock valued at $180,000 after acquiring an additional 1,188 shares during the last quarter. Institutional investors and hedge funds own 86.19% of the company’s stock.

Alignment Healthcare Company Profile

(Get Free Report)

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.

Featured Articles